Adaptive Biotechnologies (ADPT) Gains from Investment Securities (2019)
Adaptive Biotechnologies' (ADPT) quarterly Gains from Investment Securities came in at $2.2 million in Q2 2019, up 12388.89% quarter-over-quarter from $18000.0 in Q1 2019.
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) Gains from Investment Securities (2019) Analysis & Trends
Adaptive Biotechnologies has disclosed Gains from Investment Securities across 1 years of filings, most recently posting $2.2 million for Q2 2019.
- In Q2 2019, Gains from Investment Securities changed N/A year-over-year to $2.2 million; the TTM figure through Dec 2019 stood at $2.3 million (changed N/A YoY), while the FY2019 annual figure was $2.3 million, up 37866.67% from the prior year.
- Gains from Investment Securities came in at $2.2 million for Q2 2019 at Adaptive Biotechnologies, up from $18000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.2 million in Q2 2019 to a low of $18000.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn |